Commentary
When Clinical Algorithms Outpace the Markets That Serve Them : The CD4 Comeback Story Nobody Planned For
What happens to markets when advancements in clinical guidelines outpace them? A silent erosion, ultimately leading to a market collapse. The impact stretches far beyond a single player, but cuts across the entire value chain right up to the last mile, resulting in a systemic issue preventing access.
